MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, XERS made $291,845K in revenue. $554K in net income. Net profit margin of 0.19%.

Income Overview

Revenue
$291,845K
Net Income
$554K
Net Profit Margin
0.19%
Unit: Thousand (K) dollars
Revenue Breakdown
    • Product
    • Royalty Contract And Other Reven...
Revenue Breakdown
    • Recorlev
    • Gvoke
    • Keveyis
    • Others

Income Statement
2025-12-31
2024-12-31
Product revenue, net
291,845 203,070
Cost of goods sold
42,569 36,832
Research and development
31,165 25,560
Selling, general and administrative
182,372 163,481
Amortization of intangible assets
10,843 10,843
Total costs and expenses
266,949 236,716
Income (loss) from operations
24,896 -33,646
Interest and other income
4,742 5,321
Loss on debt extinguishment, net
0 -
Debt refinancing costs
0 2,690
Interest expense
29,084 30,485
Change in fair value of warrants
0 -8
Change in fair value of contingent value rights
0 -4,388
Total other expense
-24,342 -23,458
Net income (loss) before income taxes
554 -57,104
U.s. federal statutory tax rate
-116 -
State and local income taxes, net of federal income tax effect
0 -
Statutory tax rate difference between ireland and united states-IE
3,832 -
Changes in valuation allowance-IE
6,061 -
Other
49 -
Statutory tax rate difference between ireland and united states-Foreign Tax Jurisdiction Other
290 -
Subpart f income
-12,606 -
Research and development tax credits
-1,224 -
Changes in valuation allowance-US
3,712 -
Compensation subject to the section 162 limitation
-1,276 -
Stock compensation
-795 -
Non-deductible expenses
-277 -
Other adjustments
-98 -
Income tax benefit
0 -2,268
Net income (loss)
554 -54,836
Unrealized gains (losses) on investments
0 -
Comprehensive income (loss)
554 -54,836
Basic EPS
0 -0.37
Diluted EPS
0 -0.37
Basic Average Shares
160,425,198 146,772,758
Diluted Average Shares
172,742,720 146,772,758
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Product$283,003K (43.92%↑ Y/Y)Royalty Contract AndOther Revenue$8,842K (37.43%↑ Y/Y)Product revenue, net$291,845K (43.72%↑ Y/Y)Income (loss) fromoperations$24,896K (173.99%↑ Y/Y)Total costs andexpenses$266,949K (12.77%↑ Y/Y)Net income (loss)before income taxes$554K (100.97%↑ Y/Y)Total other expense-$24,342K (-3.77%↓ Y/Y)Interest and other income$4,742K (-10.88%↓ Y/Y)Selling, general andadministrative$182,372K (11.56%↑ Y/Y)Cost of goods sold$42,569K (15.58%↑ Y/Y)Research and development$31,165K (21.93%↑ Y/Y)Amortization of intangibleassets$10,843K (0.00%↑ Y/Y)Net income (loss)$554K (101.01%↑ Y/Y)Interest expense$29,084K (-4.60%↓ Y/Y)Comprehensive income (loss)$554K (101.01%↑ Y/Y)

Xeris Biopharma Holdings, Inc. (XERS)

Xeris Biopharma Holdings, Inc. (XERS)